focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.50
Bid: 314.40
Ask: 314.60
Change: -2.50 (-0.79%)
Spread: 0.20 (0.064%)
Open: 314.30
High: 315.10
Low: 313.40
Prev. Close: 317.00
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension to the trading plan in NatWest Group plc

3 Apr 2023 07:00

RNS Number : 1027V
UK Government Investments Limited
03 April 2023
 

NOT FOR DISTRIBUTION IN OR TO THE UNITED STATES (OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS), CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR IN ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW

3 April 2023

UK Government Investments Limited ("UKGI")

Extension to the trading plan in NatWest Group plc

UKGI today announces that it has agreed to extend the sale of part of His Majesty's Treasury's ("HM Treasury") shareholding in NatWest Group plc (the "Company") under the trading plan announced on 22 July 2021 and extended on 22 June 2022 (the "Trading Plan"). Following the extension, the Trading Plan will now terminate no later than 11 August 2025 instead of 11 August 2023 (unless further extended).

The Trading Plan will continue to be managed by Morgan Stanley & Co. International plc ("Morgan Stanley"). Under the Trading Plan, Morgan Stanley will have full discretion to continue to effect a measured and orderly sell down of ordinary shares in the Company (the "Shares") on behalf of HM Treasury.

The Trading Plan will continue to include provisions that (a) HM Treasury's intention is that up to, but no more than, 15% of the aggregate total trading volume in the Company will be sold during the two year extension of the Trading Plan announced today, and (b) Shares may not be sold under the Trading Plan below a price per Share that UKGI and HM Treasury determine represents fair value and delivers value for money for the taxpayer throughout the term of the Trading Plan. The actual number of Shares sold on any day under the Trading Plan will depend on market conditions, among other factors.

Since it was established, HM Treasury has realised proceeds of approximately £3.7 billion in total under the Trading Plan. HM Treasury currently owns 3,983,059,856 Shares, which represents approximately 41.5% of voting rights in the Company. HM Treasury's percentage of voting rights may increase if Shares are purchased by the Company under its ongoing share buyback programme. Any such increases will be offset (in whole or in part) by any sale of Shares under the Trading Plan.

UKGI and HM Treasury will keep other disposal options under active consideration, including by way of directed buybacks and/or accelerated bookbuilds when market conditions permit. The decision to extend the Trading Plan does not preclude HM Treasury from executing such other disposals that achieve value for money for taxpayers, including during the term of the Trading Plan.

Goldman Sachs International is acting as Privatisation Adviser to UKGI. Freshfields Bruckhaus Deringer LLP is acting as legal counsel to UKGI in respect of English and US law.

 

Contacts:

HM Treasury Press Office: +44 20 7270 5238

UKGI Press Office (for UKGI related matters): Frances Collier-Wright, +447971610050

The Panel on Takeovers and Mergers has confirmed that any increases in HM Treasury's percentage of voting rights as a result of share buybacks by the Company will not carry any consequences under Rule 9 of the City Code on Takeovers and Mergers.

This press release is for information purposes only and does not constitute or form a part of an offer to sell or a solicitation of an offer to purchase any security of the Company in the United States or in any other jurisdiction where such offer or solicitation is unlawful. The securities of the Company described in this press release have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or any applicable state or foreign securities laws and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act. There shall be no public offering of securities in the United States or any other jurisdiction.

Goldman Sachs International and Morgan Stanley & Co. International plc (together, the "Banks") are authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom. Goldman Sachs International is acting on behalf of UKGI and no one else in connection with the Trading Plan and Morgan Stanley & Co. International plc is acting on behalf of HM Treasury and UKGI and no one else in connection with the Trading Plan; accordingly neither Bank will be responsible to any other person for providing the protections afforded to any of their respective clients or for providing advice to any other person in relation to the Trading Plan. Neither of the Banks will regard any other person as its client in relation to the Trading Plan. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by either of the Banks or by any of their respective affiliates or agents as to or in relation to, the accuracy, completeness or sufficiency of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers in connection with HM Treasury, UKGI, the Company, the Trading Plan or any of the arrangements described herein, and any liability therefore is expressly disclaimed.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUCCUPWUAW
Date   Source Headline
8th Feb 20245:35 pmRNSTransaction in Own Shares
7th Feb 20245:11 pmRNSTransaction in Own Shares
6th Feb 20245:18 pmRNSTransaction in Own Shares
6th Feb 20249:30 amRNSDirectorate Change
5th Feb 20245:03 pmRNSTransaction in Own Shares
5th Feb 20249:23 amRNSHolding(s) in Company
2nd Feb 20245:08 pmRNSTransaction in Own Shares
1st Feb 20245:24 pmRNSTransaction in Own Shares
31st Jan 20245:14 pmRNSTotal Voting Rights
29th Jan 20245:22 pmRNSTransaction in Own Shares
25th Jan 20245:21 pmRNSTransaction in Own Shares
23rd Jan 20245:04 pmRNSTransaction in Own Shares
22nd Jan 20249:21 amRNSHolding(s) in Company
19th Jan 20245:08 pmRNSTransaction in Own Shares
18th Jan 20245:39 pmRNSTransaction in Own Shares
17th Jan 20245:42 pmRNSTransaction in Own Shares
16th Jan 20245:30 pmRNSTransaction in Own Shares
15th Jan 20245:58 pmRNSTransaction in Own Shares
12th Jan 20245:02 pmRNSTransaction in Own Shares
11th Jan 20245:13 pmRNSTransaction in Own Shares
10th Jan 20245:28 pmRNSTransaction in Own Shares
9th Jan 20245:04 pmRNSTransaction in Own Shares
8th Jan 20245:18 pmRNSTransaction in Own Shares
5th Jan 20245:24 pmRNSTransaction in Own Shares
4th Jan 20245:09 pmRNSTransaction in Own Shares
3rd Jan 20245:39 pmRNSTransaction in Own Shares
3rd Jan 20244:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202410:38 amRNSHolding(s) in Company
2nd Jan 20245:24 pmRNSTransaction in Own Shares
29th Dec 202312:47 pmRNSTotal Voting Rights
29th Dec 202310:30 amRNSDirector/PDMR Shareholding
28th Dec 20235:37 pmRNSTransaction in Own Shares
27th Dec 20235:18 pmRNSTransaction in Own Shares
22nd Dec 20231:27 pmRNSTransaction in Own Shares
21st Dec 20235:23 pmRNSTransaction in Own Shares
20th Dec 20235:35 pmRNSTransaction in Own Shares
19th Dec 20235:33 pmRNSTransaction in Own Shares
19th Dec 20233:00 pmRNSDirector/PDMR Shareholding
18th Dec 20235:31 pmRNSTransaction in Own Shares
15th Dec 20235:25 pmRNSTransaction in Own Shares
15th Dec 20239:00 amRNSKey findings from Phase 2 of Travers Smith review
13th Dec 20235:32 pmRNSTransaction in Own Shares
12th Dec 20235:29 pmRNSTransaction in Own Shares
11th Dec 20239:38 amRNSHolding(s) in Company
8th Dec 20239:46 amRNSPublication of a Prospectus
7th Dec 20235:18 pmRNSTransaction in Own Shares
6th Dec 20235:30 pmRNSTransaction in Own Shares
5th Dec 20235:07 pmRNSTransaction in Own Shares
4th Dec 20235:12 pmRNSTransaction in Own Shares
1st Dec 20235:41 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.